Navigation Links
FirstMark to Exhibit at Cardiovascular Research Technologies (CRT) 2012 Conference
Date:2/1/2012

WASHINGTON and SAN DIEGO, Feb. 1, 2012 /PRNewswire-iReach/ -- FirstMark is pleased to announce that it will be exhibiting at the CRT 2012 Conference in Washington D.C. on February 5 – 7. FirstMark will showcase its new cardiovascular diagnostic test PREvent. PREvent is the first and only multiple biomarker blood test on the market that predicts near term (2-3 years) risk of myocardial infarction in patients with suspected or confirmed, insignificant or significant stable CAD. The test is a critical advancement in cardiovascular medicine addressing the unmet need to assess risk of near term MI.

"CRT 2012 is a great opportunity to showcase our new cardiovascular blood test. It also gives us the chance to meet with leading cardiologists from around the country and update them first-hand on our new test, including the very impressive final data. We are proud to be a part of such a key industry event," says Thomas Silberg, President and CEO of GenWay Biotech.

Details about the test's research will be given in an oral presentation at the conference, An Aggregate of 3 Biomarkers Predict Very High Risk of Acute Myocardial Infarction and Death, by Dr. Stephen E. Epstein, Director of the Vascular Biology Laboratory and Executive Director of the Cardiovascular Research Institute, MedStar Health Research Institute at the Washington Hospital Center, 11:35 a.m. Monday, February 6. (Atherosclerosis & HDL Therapy).  

About FirstMark PREvent

FirstMark PREvent is the first and only multiple biomarker blood test on the market that predicts near term (2-3 years) risk of myocardial infarction and/or death in patients with suspected or confirmed, insignificant or significant stable CAD. PREvent aggregates three cardiovascular biomarkers that identify the pathways that lead to vulnerable plaque formation. In a clinical study, an annual average of 18.2% of patients with all th
'/>"/>

SOURCE GenWay Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. 2011 ErgoExpo Attendees Choice Award Winners Announced During Sold Out Expo; Exhibitor Renewal for 2012 Hits 96% and Counting
2. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
3. ALTEN and Calsoft Labs at the BWF 2011 Exhibition
4. Selexis SA to Partner and Exhibit at BIO 2011 in Washington DC
5. China Botanic Exhibits All-Natural Products at the 65th PHARMACHINA Fair
6. VENENUM Biodesign to Exhibit at SBS
7. Sensus Healthcare Announces Its Exhibitor Attendance at the 9th Annual South Beach Symposiumâ„¢
8. Nanowires exhibit giant piezoelectricity
9. At RSNA, DR Systems Will Exhibit New Unity v-Series Web PACS
10. WAVE Conference and Exhibition 2011 Taking Products to Market incorporating Micro & Nano Technology
11. Graphene exhibits bizarre new behavior well suited to electronic devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... According to Ross Selinger, President of Selinger ... the national office market continues to be strong, driven by ... by the third quarter’s surprising 3.9% GDP, unemployment decreasing to ... have held inflation down and the Fed is keeping interest ... remaining soft. , This solid economic news is having a ...
(Date:12/24/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... Shandong Taibang Biological Products Co. Ltd., has received ... Food and Drug Administration (the "CFDA") for its ... in the Company,s public filings, the CFDA inspected ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 /PRNewswire/ ... study of mazindol in children with attention deficit/hyperactivity disorder ... December 2014 . The paper, titled ... attention deficit/hyperactivity disorder" ( Konofal et al, ... eCollection 2014 ) shows that mazindol might be ...
(Date:12/22/2014)... 22, 2014 GenomeDx Biosciences today announced that ... Classifier, a genomic test for prostate cancer, was able ... managed by radical prostatectomy without adjuvant therapy. Although rapid ... uncommon, using tumor genomics to identify these men who ... an important advance. The study has been published ...
Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3
... Finesse Solutions, LLC, a,manufacturer of measurement and control ... its new sales and service center in,Northborough, MA, in ... Solutions is converting its Irvine, CA facility to a,service ... also plans on,opening a European sales and service center ...
... MITI ), a biopharmaceutical company developing novel, ... autoimmune,diseases, today announced that it will host a ... 2008, at 9:00 am Eastern Time (2:00 pm,Central ... full year 2007,financial results. Micromet anticipates releasing its ...
... PharmAthene, Inc., a,biodefense company specializing in the ... biological threats, announced,today that it has completed the ... spectrum chemical nerve agent prophylaxis., The PK ... used the final,pegylated version of rBChE for the ...
Cached Biology Technology:Finesse Solutions Expands by Opening Sales and Service Centers 2Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results 2PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 2PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 3PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 4
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "Global Facial ... http://photos.prnewswire.com/prnh/20130307/600769 ... the identification of individuals. Facial recognition system measures ... as nose, jaw edges, mouth, and the distance ...
(Date:12/11/2014)... 2014  That blood pressure plays a role in human ... the medical term for high blood pressure – was first ... inflatable cuff that,s used in measuring blood pressure was invented ... new about hypertension, its triggers and its effects. In fact, ... and the best ways to treat it. For ...
(Date:12/10/2014)... -- Valencell, a leader in performance biometric data sensor technology, ... its licensees for highly accurate, clinically validated biometric technology. ... from fitness and health sectors, but first responders/military and ... only as useful as the biometric data it delivers. ... long-term mass consumer adoption of wearable products," said Dr. ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Leaders within the U.S. biomedical device industry unveiled today ... enhance the development of devices with great clinical utility, ... become a key component of the nation,s drive to ... access to device innovation that improves human health, the ...
... OF PRUSSIA, Pa., June 16, 2011 Omnicare Clinical Research, ... re-branding of the company under the name Theorem Clinical Research. ... separation from its former parent company in a deal that ... private equity firm based in Providence, R.I., acquired the CRO ...
... eruption in early June, several NASA satellites have captured images ... Volcano called Puyehue-Cordn Caulle and have tracked it around the ... image gallery that shows the progression of the plume around ... includes the Puyehue volcano, the Cordn Caulle rift zone and ...
Cached Biology News:U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering" 2U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering" 3U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering" 4Omnicare Clinical Research Re-Brands as Theorem Clinical Research 2Omnicare Clinical Research Re-Brands as Theorem Clinical Research 3NASA satellite gallery shows Chilean volcano plume moving around the world 2NASA satellite gallery shows Chilean volcano plume moving around the world 3
... internal standard for the quantification of 5-OxoETE ... is a polyunsaturated keto acid formed by ... It stimulates cytosolic calcium levels in neutrophils ... selectively stimulates the migration and degranulation of ...
... 4,600 to Over 3 Million Genotypes Per ... capable of performing 4,600 to over 3 ... GenomeLab family of products*, this automated, scalable, ... SNPs in each well of an arrayed ...
... These protein size markers are a mixture ... 16 to 100 kDa. The markers provide ... gels after staining with Coomassie blue. Because ... II sequence, the markers can also be ...
... solid. A nucleoside antibiotic that inhibits ... of N-glycosidic protein-carbohydrate linkages. Active ... yeasts, fungi, and viruses. Inhibits the ... human T-lymphoblastoid cells. Also inhibits thrombin-induced ...
Biology Products: